Hyseq Gains Patent for Biochip Probe Set

The U.S. Patent and Trademark office has issued Hyseq Inc. (Sunnyvale, CA) U.S. Patent No. 6,018,041, which covers sets of probes of known sequence, any subset of which overlaps along a sample—the type of probe set used for many biochips.

"We believe our patent portfolio now covers elements important to many biochips and their use. Our core SBH patents cover methods of use," said Lewis S. Gruber, Hyseq's president and CEO. "This new '041 patent covers a type of probe used on many biochips. We also have filed patent applications on more than 900,000 partial and full length gene sequences that can be used as content for biochips."

Hyseq is developing biopharmaceuticals to treat acute and chronic conditions in the immunology, hemopoetic, and cardiovascular areas. Hyseq uses its high-throughput proprietary technology for discovering and developing therapeutic product candidates and for pharmacogenomic and polymorphism analysis.

For more information: Radoje Drmanac, Chief Scientific Officer, Hyseq Inc., 670 Almanor Ave., Sunnyvale, CA 94086. Tel: 408-524-8100. Fax: 408-524-8141.

Edited by Jim Pomager